Mikhail Blagosklonny

Mikhail Blagosklonny
Fields	Anti-aging medicine, oncology
Institutions	Roswell Park Cancer Institute
Alma mater	First Pavlov State Medical University of St. Peterburg

Mikhail Blagosklonny is a scientist who studies cancer and aging. He is a professor of oncology at the Roswell Park Cancer Institute in New York.

Blagosklonny earned both his M.D. in internal medicine and his PhD in experimental medicine and cardiology from the First Pavlov State Medical University of St. Peterburg. He was appointed associate professor of medicine at New York Medical College, Valhalla, NY in 2002 before taking a position as a senior scientist at Ordway Research Institute (Albany, New York). Blagosklonny held this position until 2009 when he was appointed professor of oncology at Roswell Park Cancer Institute.

Blogosklonny's research interests include cancer and targeted cancer therapies that protect normal cells from damage, as well as the underlying mechanisms of aging (biogerontology) and anti-aging drugs.

Blagosklonny has formulated a hypothesis about the possible role of TOR signaling in aging and cancer and proposed using rapamycin, a popular cancer drug as a possible treatment for life extension. He is considered one of the most passionate advocates for rapamycin in longevity research.

Blagosklonny is editor-in-chief of Aging,Cell Cycle, and Oncotarget. In addition, he is associate editor of Cancer Biology & Therapy and a member of the editorial board of Cell Death & Differentiation.

...
Wikipedia